SuPine Therapeutics

SuPine Therapeutics is a regenerative biotechnology company developing next-generation therapies for spinal cord injury, one of the world’s most severe unmet medical needs. The company is advancing stem cell- and biomaterial-based therapeutic approaches designed to support tissue regeneration and functional recovery. In parallel, SuPine is building stem cell-based, human-relevant testing platforms that aim to reduce reliance on animal experimentation and improve predictive biology in drug development. Its mission is to advance ethically responsible regenerative medicine that addresses critical patient needs while supporting more humane and translational research models.